Literature DB >> 18246804

[Clinical analysis of 110 patients with primary gallbladder carcinoma].

Yong-Liang Chen1, Zhi-Qiang Huang, Ning-Xin Zhou, Wen-Zhi Zhang, Xiao-Qiang Huang, Wei-Dong Duan, Rong Liu, Yang Liu.   

Abstract

OBJECTIVE: To investigate the clinical characteristics of primary gallbladder carcinoma.
METHODS: The data of clinical manifestations, image characteristics, diagnosis and treatment of 110 patients with primary gallbladder carcinoma were analyzed.
RESULTS: The rate of diagnosis as early primary gallbladder carcinoma was only 8.2% (9/110) in this series. The majority of the patients were females (63/110) with an age ranging from 31 to 80 years. Clinical manifestations were not specific, and diagnosis was made mainly on image examination. Radical resection was performed for 57 patients, palliative resection for 41, the rest 12 patients failed to receive operation on reasons of distant metastasis, age or other reasons. Only 88 patients were followed with a mean survival time of 196 days ranging from 15 days to 5 years and 11 months.
CONCLUSION: The primary gallbladder carcinoma is quite difficult to diagnose at the early stage, and its prognosis is usually poor. The diagnosis is made mainly depending on the medical history and image examinations.

Entities:  

Mesh:

Year:  2007        PMID: 18246804

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  3 in total

1.  Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line GBC-SD.

Authors:  Bao-bing Yin; Shuang-jie Wu; Hua-jie Zong; Bao-jin Ma; Duan Cai
Journal:  J Zhejiang Univ Sci B       Date:  2011-04       Impact factor: 3.066

2.  miR-125b suppresses cellular proliferation by targeting c-FLIP in gallbladder carcinoma.

Authors:  Huajie Zong; Huading Zhou; Yang Xiang; Gang Wu
Journal:  Oncol Lett       Date:  2019-10-18       Impact factor: 2.967

3.  MicroRNA-135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer.

Authors:  Huading Zhou; Weijie Guo; Yingjun Zhao; Yifei Wang; Ruopeng Zha; Jie Ding; Linhui Liang; Guanghua Yang; Zongyou Chen; Baojin Ma; Baobing Yin
Journal:  Cancer Sci       Date:  2014-08       Impact factor: 6.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.